Effects of Maternal Subclinical Hypothyroidism in Early Pregnancy Diagnosed by Different Criteria on Adverse Perinatal Outcomes in Chinese Women With Negative TPOAb.

Mei-Fang Li, Li Ma, Qi-Ming Feng, Yue Zhu, Tian-Pei Yu, Jiang-Feng Ke, Zhi-Hui Zhang, Yun Liu, Lian-Xi Li
Author Information
  1. Mei-Fang Li: Department of Emergency, Shanghai JiaoTong University Affiliated Sixth People's Hospital, Shanghai, China.
  2. Li Ma: Department of Obstetrics and Gynecology, Shanghai Clinical Center for Severe Maternal Rescue, Shanghai JiaoTong University Affiliated Sixth People's Hospital, Shanghai, China.
  3. Qi-Ming Feng: Department of Emergency, Shanghai JiaoTong University Affiliated Sixth People's Hospital, Shanghai, China.
  4. Yue Zhu: Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinical Center for Metabolic Disease, Shanghai, China.
  5. Tian-Pei Yu: Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinical Center for Metabolic Disease, Shanghai, China.
  6. Jiang-Feng Ke: Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinical Center for Metabolic Disease, Shanghai, China.
  7. Zhi-Hui Zhang: Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinical Center for Metabolic Disease, Shanghai, China.
  8. Yun Liu: Department of Information, Department of Medical Information, School of Biomedical Engineering and Informatics, The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Jiangsu, China.
  9. Lian-Xi Li: Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinical Center for Metabolic Disease, Shanghai, China.

Abstract

To compare the effects of maternal subclinical hypothyroidism (SCH) diagnosed by the 2011 or 2017 "Guidelines of the American Thyroid Association (ATA) for the diagnosis and management of thyroid disease during pregnancy and the postpartum" during the first trimester on adverse pregnancy outcomes in thyroid peroxidase antibody (TPOAb)-negative pregnant women. There were 1,556 Chinese singleton pregnant women with negative TPOAb diagnosed with either SCH or euthyroidism who were investigated, and the prevalence and risk of obstetric outcomes were compared between the two groups using 2011 and 2017 ATA standards, respectively. The effects of a mildly elevated thyroid-stimulating hormone (TSH) concentration on adverse pregnancy outcomes were evaluated by binary logistic regression. Maternal SCH identified by the 2011 ATA guidelines correlated with higher rates and risks of pregnancy-induced hypertension (PIH), preeclampsia, and low-birth-weight infants, while maternal SCH diagnosed by the 2017 ATA guidelines was more likely to develop PIH, preeclampsia, cesarean delivery, preterm delivery, placenta previa, and total adverse maternal and neonatal outcomes. Moreover, a mildly elevated TSH level was significantly associated with PIH after adjustment for confounding factors. Compared with the 2011 ATA guidelines, the 2017 ATA guidelines could be more applicable to Chinese pregnant women to screen the effects of SCH on the majority of adverse pregnancy outcomes.

Keywords

References

  1. Arch Gynecol Obstet. 2013 Jan;287(1):1-7 [PMID: 23104052]
  2. PLoS One. 2014 Oct 29;9(10):e109364 [PMID: 25353960]
  3. Arch Endocrinol Metab. 2016 Aug;60(4):314-8 [PMID: 26886091]
  4. J Clin Transl Endocrinol. 2013 Dec 24;1(1):e13-e17 [PMID: 29235583]
  5. J Clin Endocrinol Metab. 1994 Jul;79(1):197-204 [PMID: 8027226]
  6. Obstet Gynecol. 2005 Feb;105(2):239-45 [PMID: 15684146]
  7. Thyroid. 2018 May;28(5):551-555 [PMID: 29644934]
  8. Endocr Rev. 2010 Oct;31(5):702-55 [PMID: 20573783]
  9. Thyroid. 2019 Feb;29(2):278-289 [PMID: 30444186]
  10. Obstet Gynecol. 2012 Feb;119(2 Pt 1):315-20 [PMID: 22270283]
  11. Obstet Gynecol. 2008 Jul;112(1):85-92 [PMID: 18591312]
  12. BMJ. 2015 Oct 12;351:h4726 [PMID: 26459315]
  13. Obstet Gynecol. 1993 Mar;81(3):349-53 [PMID: 8437784]
  14. Thyroid. 2011 Oct;21(10):1081-125 [PMID: 21787128]
  15. Arch Gynecol Obstet. 2015 May;291(5):1047-54 [PMID: 25388918]
  16. Iran J Reprod Med. 2015 Jul;13(7):387-96 [PMID: 26494985]
  17. J Clin Endocrinol Metab. 2003 Aug;88(8):3731-7 [PMID: 12915662]
  18. Eur J Obstet Gynecol Reprod Biol. 2017 Mar;210:366-369 [PMID: 28153744]
  19. J Clin Endocrinol Metab. 2014 Jan;99(1):73-9 [PMID: 24276458]
  20. Best Pract Res Clin Endocrinol Metab. 2011 Dec;25(6):875-84 [PMID: 22115163]
  21. Front Endocrinol (Lausanne). 2019 Aug 06;10:522 [PMID: 31447778]
  22. J Clin Endocrinol Metab. 2018 Mar 1;103(3):926-935 [PMID: 29126290]
  23. Thyroid. 2012 Dec;22(12):1200-35 [PMID: 22954017]
  24. JAMA Intern Med. 2015 Nov;175(11):1872-3 [PMID: 26524757]
  25. Diabetes Res Clin Pract. 2020 Mar;161:108085 [PMID: 32061817]
  26. J Clin Endocrinol Metab. 2011 Oct;96(10):3234-41 [PMID: 21832110]
  27. Thyroid. 2005 May;15(5):474-7 [PMID: 15929669]
  28. BMC Endocr Disord. 2018 Sep 12;18(1):64 [PMID: 30208865]
  29. Am J Obstet Gynecol. 2015 Oct;213(4):565.e1-6 [PMID: 26164693]
  30. J Clin Endocrinol Metab. 2010 Mar;95(3):1084-94 [PMID: 20080846]
  31. J Matern Fetal Neonatal Med. 2016 Dec;29(24):3971-6 [PMID: 26988121]
  32. J Matern Fetal Neonatal Med. 2017 Sep;30(18):2174-2178 [PMID: 27677438]
  33. Obstet Gynecol. 2012 May;119(5):983-8 [PMID: 22525909]
  34. J Reprod Med. 2006 Jan;51(1):59-63 [PMID: 16482779]
  35. Thyroid. 2017 Mar;27(3):315-389 [PMID: 28056690]
  36. J Clin Endocrinol Metab. 2010 Sep;95(9):E44-8 [PMID: 20534758]

MeSH Term

Adult
Autoantibodies
China
Female
Fetal Diseases
Humans
Hypothyroidism
Infant, Newborn
Pregnancy
Pregnancy Complications
Pregnancy Outcome
Pregnancy Trimester, First
Premature Birth
Prenatal Exposure Delayed Effects
Thyrotropin

Chemicals

Autoantibodies
thyroid microsomal antibodies
Thyrotropin

Word Cloud

Created with Highcharts 10.0.0outcomesATAadverseSCHpregnancyguidelinesmaternal20112017effectsdiagnosedthyroidTPOAbpregnantwomenChinesePIHsubclinicalhypothyroidismAmericanmildlyelevatedTSHMaternalpreeclampsiadeliveryneonatalcompare"GuidelinesThyroidAssociationdiagnosismanagementdiseasepostpartum"firsttrimesterperoxidaseantibody-negative1556singletonnegativeeithereuthyroidisminvestigatedprevalenceriskobstetriccomparedtwogroupsusingstandardsrespectivelythyroid-stimulatinghormoneconcentrationevaluatedbinarylogisticregressionidentifiedcorrelatedhigherratesriskspregnancy-inducedhypertensionlow-birth-weightinfantslikelydevelopcesareanpretermplacentapreviatotalMoreoverlevelsignificantlyassociatedadjustmentconfoundingfactorsComparedapplicablescreenmajorityEffectsSubclinicalHypothyroidismEarlyPregnancyDiagnosedDifferentCriteriaAdversePerinatalOutcomesWomenNegativeassociation

Similar Articles

Cited By